Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management

Immune checkpoint inhibitors (ICIs) that target cytotoxic T lymphocyte antigen 4, programmed cell death-1, and PD-ligand 1 have revolutionized cancer treatment, achieving unprecedented efficacy in multiple malignancies. ICIs are increasingly being used in early cancer settings and in combination wit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Pharmacol
Autores principales: Zhou, Yu-Wen, Zhu, Ya-Juan, Wang, Man-Ni, Xie, Yao, Chen, Chao-Yue, Zhang, Tao, Xia, Fan, Ding, Zhen-Yu, Liu, Ji-Yan
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6897286/
https://ncbi.nlm.nih.gov/pubmed/31849640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01350
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares